Literature DB >> 17465945

Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.

Norbert Ahrens1, Axel Pruss, Andreas Kähne, Holger Kiesewetter, Abdulgabar Salama.   

Abstract

BACKGROUND: Autoantibodies (AUTO) to red blood cells (RBCs) are frequently associated with alloantibodies (ALLO). The mechanism for the coexistence of these antibodies is obscure. STUDY DESIGN AND METHODS: Between August 1998 and June 2006, all in- and outpatients of the Charité University Hospital, Berlin, with detectable AUTO were included in this study. Serologic examination was performed with standard techniques for the detection of RBC antibodies.
RESULTS: A total of 717 patients were found to have AUTO, with ALLO observed in 200 of these patients (28%). The history of antibody production could be evaluated in 98 of the 200 patients. Both AUTO and ALLO were due to RBC transfusion in 73 cases (75%) and peripheral blood progenitor cell transplantation in 6 cases (6%). Nine (9%) patients were primarily alloimmunized and subsequently developed AUTO. The remaining 10 (10%) patients were primarily autoimmunized and later developed ALLO. Only 6 of these patients had chronic idiopathic autoimmune hemolytic anemia.
CONCLUSION: The majority of AUTO associated with ALLO appears to be due to RBC transfusion that must be recognized as a major cause for autoimmunization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465945     DOI: 10.1111/j.1537-2995.2007.01194.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  19 in total

1.  Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.

Authors:  Rakchha Chhetri; Li Yan A Wee; Romi Sinha; Monika M Kutyna; Anh Pham; Helen Stathopoulos; Lakshmi Nath; Shriram V Nath; Nicholas Wickham; Tim Hughes; Deepak Singhal; David J Roxby; Devendra K Hiwase
Journal:  Haematologica       Date:  2019-02-28       Impact factor: 9.941

2.  Increased detection of clinically significant antibodies and decreased incidence of delayed haemolytic transfusion reaction with the indirect antiglobulin test potentiated by polyethylene glycol compared to albumin: a Japanese study.

Authors:  Miho Okutsu; Hitoshi Ohto; Hiroyasu Yasuda; Kinuyo Kawabata; Satoshi Ono; Shunnichi Saito; Akiko Sugawara; Masami Kikuchi; Saori Miura; Youko Ishii; Kazuya Watanabe; Yuriko Tohyama; Kenneth E Nollet
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

3.  Precautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimated.

Authors:  Salih Yürek; Beate Mayer; Mohammed Almahallawi; Axel Pruss; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2015-06-16       Impact factor: 3.443

4.  HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.

Authors:  Marianne E McPherson; Alan R Anderson; Marta-Inés Castillejo; Christopher D Hillyer; Robert A Bray; Howard M Gebel; Cassandra D Josephson
Journal:  Pediatr Blood Cancer       Date:  2010-04       Impact factor: 3.167

5.  Clearance of pathological antibodies using biomimetic nanoparticles.

Authors:  Jonathan A Copp; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Weiwei Gao; Kang Zhang; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

6.  'Chameleonic' Serological Findings Leading to Life-Threatening Hemolytic Transfusion Reactions.

Authors:  Ariane Sümnig; Beate Mayer; Volker Kiefel; Andreas Greinacher; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-04       Impact factor: 3.747

7.  Harmless Pregnancy-Induced Warm Autoantibodies to Red Blood Cells.

Authors:  Gülüstan Sürücü; Beate Mayer; Anneliese Märzacker; Salih Yürek; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-09-10       Impact factor: 3.747

Review 8.  Clinically and/or Serologically Misleading Findings Surrounding Immune Haemolytic Anaemias.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

9.  Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.

Authors:  Mohamed Bejaoui; Naouel Guirat
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

10.  Alternative blood products and clinical needs in transfusion medicine.

Authors:  Carolyn Whitsett; Stefania Vaglio; Giuliano Grazzini
Journal:  Stem Cells Int       Date:  2012-04-08       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.